CD83 Expression Influences CD4+ T Cell Development in the Thymus

Slides:



Advertisements
Similar presentations
Volume 19, Issue 3, Pages (September 2003)
Advertisements

Volume 8, Issue 1, Pages (January 1998)
Volume 9, Issue 4, Pages (October 1998)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 5, Issue 3, Pages (September 1996)
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Volume 31, Issue 5, Pages (November 2009)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 19, Issue 6, Pages (December 2003)
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 9, Issue 3, Pages (September 1998)
Volume 19, Issue 2, Pages (August 2003)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 24, Issue 3, Pages (March 2006)
Aiolos Regulates B Cell Activation and Maturation to Effector State
Volume 19, Issue 3, Pages (September 2003)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
CD22 is a negative regulator of B-cell receptor signalling
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Volume 33, Issue 6, Pages (December 2010)
Volume 24, Issue 3, Pages (March 2006)
Ku86-Deficient Mice Exhibit Severe Combined Immunodeficiency and Defective Processing of V(D)J Recombination Intermediates  Chengming Zhu, Molly A Bogue,
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 28, Issue 6, Pages (June 2008)
Volume 31, Issue 5, Pages (November 2009)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Notch1 Signaling Promotes the Maturation of CD4 and CD8 SP Thymocytes
Volume 9, Issue 5, Pages (November 1998)
Volume 14, Issue 5, Pages (May 2001)
Impaired Initiation of Contact Hypersensitivity by FTY720
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 27, Issue 3, Pages (September 2007)
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors  Na Xiong, Chuhlo Kang,
Volume 43, Issue 5, Pages (November 2015)
Volume 12, Issue 5, Pages (May 2000)
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 19, Issue 3, Pages (September 2003)
Volume 15, Issue 5, Pages (November 2001)
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 27, Issue 3, Pages (September 2007)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Leukocyte Migration Is Regulated by L-Selectin Endoproteolytic Release
Volume 85, Issue 5, Pages (May 1996)
Volume 21, Issue 1, Pages (October 2017)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 28, Issue 5, Pages (May 2008)
Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker  Immunity 
Volume 16, Issue 3, Pages (March 2002)
Volume 21, Issue 1, Pages (October 2017)
Volume 9, Issue 3, Pages (September 1998)
Volume 94, Issue 2, Pages (July 1998)
David A Schwarz, Carol D Katayama, Stephen M Hedrick  Immunity 
Volume 17, Issue 1, Pages (July 2002)
Volume 23, Issue 4, Pages (October 2005)
Volume 10, Issue 2, Pages (February 1999)
Volume 22, Issue 3, Pages (March 2005)
Volume 28, Issue 1, Pages (January 2008)
Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial.
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 4, Issue 5, Pages (May 1996)
Volume 13, Issue 21, Pages (October 2003)
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

CD83 Expression Influences CD4+ T Cell Development in the Thymus Yoko Fujimoto, LiLi Tu, Ann S. Miller, Cheryl Bock, Manabu Fujimoto, Carolyn Doyle, Douglas A. Steeber, Thomas F. Tedder  Cell  Volume 108, Issue 6, Pages 755-767 (March 2002) DOI: 10.1016/S0092-8674(02)00673-6

Figure 1 CD83 Gene Disruption (A) CD83 exons encoding untranslated (filled squares) and translated (open squares) regions. (B) The gene-targeting vector contained thymidine kinase (tk) and neomycin resistance (neor) genes. (C) Gene targeting reduced a 17 kb EcoR I DNA cleavage product to 8.5 kb. (D) Southern analysis of DNA from one targeted ES cell clone and littermate offspring from crosses of heterozygous CD83+/− mice. Genomic DNA was digested with EcoR I and hybridized with the DNA probe shown. (E) CD83 expression by LPS-stimulated BM-DC generated from CD83−/− and wild-type (CD83+/+) littermates. RNA was reverse transcribed and PCR amplified using primers within the 5′ and 3′ untranslated regions (internal to the Hinc II site in exon 5), which generated a 660 bp fragment when full-length CD83 transcripts were present. Actin was amplified as a control. Results in (D) and (E) represent three littermate pairs. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 2 CD4+ T Cell Deficiency in CD83−/− Mice (A) Immunofluorescence staining of thymocytes from CD83−/− and wild-type littermates. The percentage of cells with CD4+ SP, CD8+ SP, DN, or DP phenotypes are shown for each quadrant. Mean numbers of thymocytes in each subset are shown for six littermate pairs. (B) Circulating lymphocytes from CD83−/− and wild-type littermates. Mean numbers of (C) T cells and (E) B220+ B cells and within blood (cells/ml), spleen, and pooled inguinal, axial, and cervical lymph nodes (LN) from 5–8 littermate pairs. (D) TCRβ chain, CD3, and CD5 cell surface expression by circulating CD4+ T cells as determined by three-color immunofluorescence analysis. Each symbol represents one mouse. Asterisks indicate significantly different sample means between littermate pairs, p < 0.05. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 3 CD4+ T Cell Deficiency in CD83−/− AND Mice (A) Thymocyte subsets in representative CD83−/− AND and AND littermates. Mean numbers from four littermate pairs are shown. (B) Vα11 and CD4 expression by lymphocytes from pooled inguinal, axial, and cervical lymph nodes. (C) Mean numbers of lymphocytes from four pairs of CD83−/− AND and AND littermates. Asterisks indicate significantly different means between littermate pairs, p < 0.05. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 4 Epithelial and DC Expression of CD83 (A) Thymus sections from wild-type and CD83−/− littermates stained for CD205. Cortical epithelial cells were stained most intensely (upper right in images). Arrows indicate representative CD205+ medullary DCs (magnification, 400×). (B) In situ hybridization of CD83 antisense oligonucleotide probe in thymus (40× and 400× magnification). Transcript-positive cells are stained red with hematoxylin (blue) counterstain. (C) CD83 expression by purified thymic DCs (CD205+ CD11c+), thymic epithelial cells (TEC; CD205+ CD11−), and DP thymocytes (Thy). Equal amounts of RNA from each cell population was reverse transcribed, diluted in 10-fold increments, and PCR amplified using CD83-, keratin-, or HPRT-specific primers. (D) CD83 expression by cultured BM-DC, whole thymus, and purified splenic T and B cells. Lanes labeled 1, 1/10, 1/100, and 1/1000 represent the PCR products from each dilution. (C) and (D) results represent those obtained using at least three littermate pairs of mice. (E) CD4 SP thymocytes in thymic lobes of CD83−/− mice injected with cultured thymic epithelial cells or purified thymic or splenic DC from either wild-type or CD83−/− donors. Each symbol represents results from individual thymic lobes. (F) Phenotypes of BM-DC generated from CD83−/− and wild-type littermates. Results represent at least three littermate pairs of mice. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 5 CD83−/− Thymocytes Develop Normally in Wild-Type Mice (A) Bone marrow cells from CD83−/− AND and AND littermates were transplanted into irradiated CD83−/− and wild-type littermates. (B) Thymocytes from CD83−/− AND and AND littermates were transplanted into the thymus of irradiated CD83−/− and wild-type littermates. (A) Four and (B) three weeks later, the relative percentages of Vα11+ cells expressing CD4 and/or CD8 were assessed in the thymus and spleen. These results represent those shown in Table 1. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 6 Intrinsic DC and T Cell Function in CD83−/− Mice (A) Contact hypersensitivity in CD83−/− and wild-type littermates. Values represent mean thickness of oxazolone- or carrier-challenged ear lobes in six CD83−/− and eight wild-type littermates. Significant differences between sample means are indicated; asterisks indicate p < 0.05. (B) Capacity of BM-DC from CD83−/− and wild-type littermates to stimulate allogeneic CD4+ T cells in MLR assays. (C) Proliferative capacity of splenic CD4+ T cells from CD83−/− and wild-type littermates in response to allogeneic DC in MLR assays. (D and E) Proliferation of splenic CD4+ T cells from CD83−/− and wild-type littermates in response to PHA and anti-TCR antibody. (B–E) Values represent mean counts obtained from triplicate cultures and represent those obtained in four independent experiments. (F) BrdU uptake by circulating naive and memory CD4+ T cells. Each value represents the number of BrdU+ CD4+ T cells per milliliter of blood in individual mice after BrdU uptake over a 30 day period. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)

Figure 7 B Cell Function in CD83−/− Mice (A) Humoral immune responses of CD83−/− and wild-type littermates after immunization with a T cell-dependent antigen. Six mice in each group were immunized on day 0 and boosted on day 21. Significant differences are indicated; asterisks indicate p < 0.05. (B) Serum immunoglobulin levels in CD83−/− and wild-type littermates. Symbols represent results from individual mice as determined by ELISA. (C) Proliferation of splenic B cells in response to LPS and anti-IgM antibody. Values represent mean counts obtained from triplicate cultures and represent those obtained in four independent experiments. (D) MHC class II antigen and CD86 expression by resting and LPS-stimulated splenic B cells after 24 hr. Values represent the mean fluorescence intensity of antigen expression as determined by flow cytometry analysis of cells from three CD83−/− and wild-type littermates. Cell 2002 108, 755-767DOI: (10.1016/S0092-8674(02)00673-6)